DATROWAY Demonstrated Statistically Significant and Clinically Meaningful Improvement in Overall Survival as First-Line Therapy for Patients with Metastatic Triple Negative Breast Cancer for Whom Immunotherapy Was Not an Option in TROPION-Breast02
Daiichi Sankyo and AstraZeneca’s DATROWAY is the first and only therapy to…
LIS Technologies Inc. Appoints Subject Matter Expert John Olvera as its Integrated Safety Analysis Manager
Oak Ridge, Tennessee, Aug. 22, 2025 (GLOBE NEWSWIRE) -- LIS Technologies Inc.…
Geospace Technologies Acquires National Lab Developed Heartbeat Detector Technology
Advanced Analytics Detection Product Adds to the Company’s Security PortfolioHOUSTON--(BUSINESS WIRE)--#energyexploration--Geospace Technologies…
DATROWAY Continues to Show Promising Tumor Responses as Part of Combination Regimens in Patients with Early and Advanced Non-Small Cell Lung Cancer
TROPION-Lung02 and TROPION-Lung04 phase 1b results support combination of Daiichi Sankyo and…